Comments

Pliant Therapeutics Insider Trading Activity

PLRXNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$1.25

0.0050.40%

Last update: Dec 16, 10:22 AM

Overview News Earnings Options Analyst Ratings

Insider Trades

Short Interest Stock Report

Pliant Therapeutics Insider Trading Activity | NASDAQ:PLRX | Benzinga

Track the latest Pliant Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Pliant Therapeutics stock.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are Pliant Therapeutics Inc Insiders Doing?

Insiders have report no purchases/sales in the last 30 days.

Notable Recent Insider Buys and Sales

There has been no Insider buying or selling in the last 90 days.

Ownership Statistics for Pliant Therapeutics Inc

Shares Outstanding

61.449M

Insider Shares Owned

1.723M

Insider Percentage Owned

2.80%

Institutional Shares Held

6.367M

Institutional Percentage Held

10.4%


Jan 22, 2025	Bernard Coulie	PRESIDENT AND CEO	-52.42K	$11.20	-$587.15K	SELL	-5.87%	839.83K	Jan 17	View
Jan 22, 2025	Lamont Keith Cummings	CHIEF FINANCIAL OFFICER	-20.15K	$11.20	-$225.68K	SELL	-7.13%	262.61K	Jan 17	View
Jan 22, 2025	Hans Hull	CHIEF BUSINESS OFFICER	-15.94K	$11.20	-$178.50K	SELL	-6.60%	225.54K	Jan 17	View
Jan 22, 2025	Eric Lefebvre	CHIEF MEDICAL OFFICER	-18.48K	$11.20	-$206.97K	SELL	-8.67%	194.57K	Jan 17	View
Jan 22, 2025	Lily Cheung	CHIEF HUMAN RESOURCE OFFICER	-3.74K	$11.20	-$41.89K	SELL	-13.22%	24.55K	Jan 17	View
Jan 22, 2025	Mike Ouimette	GENERAL COUNSEL & CORP. SEC'Y	-23.50K	$11.11	-$261.10K	SELL	-24.99%	70.54K	Jan 17 - Jan 22	View
Jul 12, 2024	Eric Lefebvre	CHIEF MEDICAL OFFICER	-12.32K	$11.56	-$142.41K	SELL	-5.47%	213.05K	Jul 10	View
Jul 12, 2024	Hans Hull	CHIEF BUSINESS OFFICER	-9.90K	$11.56	-$114.44K	SELL	-3.94%	241.48K	Jul 10	View
Jul 12, 2024	Lamont Keith Cummings	CHIEF FINANCIAL OFFICER	-10.91K	$11.56	-$126.13K	SELL	-3.72%	282.12K	Jul 10	View
Jul 12, 2024	Bernard Coulie	PRESIDENT AND CEO	-38.71K	$11.56	-$447.49K	SELL	-4.16%	892.25K	Jul 10	View
Jul 12, 2024	Mike Ouimette	GENERAL COUNSEL & CORP. SEC'Y	-7.66K	$11.56	-$88.50K	SELL	-7.53%	94.04K	Jul 10	View
Jan 19, 2024	Lamont Keith Cummings	CHIEF FINANCIAL OFFICER	-9.78K	$17.23	-$168.53K	SELL	-4.79%	194.60K	Jan 17	View
Jan 19, 2024	Hans Hull	CHIEF BUSINESS OFFICER	-9.79K	$17.23	-$168.61K	SELL	-4.69%	199.05K	Jan 17	View
Jan 19, 2024	Bernard Coulie	PRESIDENT AND CEO	-25.72K	$17.23	-$443.17K	SELL	-3.42%	725.70K	Jan 17	View
Jan 19, 2024	Eric Lefebvre	CHIEF MEDICAL OFFICER	-10.29K	$17.23	-$177.38K	SELL	-6.16%	156.92K	Jan 17	View
Jan 19, 2024	Mike Ouimette	GENERAL COUNSEL & CORP. SEC'Y	-5.20K	$17.23	-$89.54K	SELL	-8.60%	55.25K	Jan 17	View
Aug 07, 2023	Hans Hull	CHIEF BUSINESS OFFICER	-20.73K	$12.34	-$604.55K	SELL	-9.03%	208.84K	Aug 03 - Aug 04	View
Jul 21, 2023	Mike Ouimette	GENERAL COUNSEL & CORP. SEC'Y	-4.75K	$17.55	-$83.45K	SELL	-7.29%	60.44K	Jul 20	View
Jul 19, 2023	Mike Ouimette	GENERAL COUNSEL & CORP. SEC'Y	-12.78K	$18.01	-$230.12K	SELL	-16.39%	65.20K	Jul 17	View
Jul 19, 2023	Eric Lefebvre	CHIEF MEDICAL OFFICER	-22.32K	$18.01	-$401.98K	SELL	-11.78%	167.22K	Jul 17	View
Jul 19, 2023	Hans Hull	CHIEF BUSINESS OFFICER	-17.94K	$18.01	-$323.03K	SELL	-7.14%	233.17K	Jul 17	View
Jul 19, 2023	Lamont Keith Cummings	CHIEF FINANCIAL OFFICER	-19.77K	$18.01	-$356.06K	SELL	-8.84%	204.00K	Jul 17	View
Jul 19, 2023	Bernard Coulie	PRESIDENT AND CEO	-70.15K	$18.01	-$1.26M	SELL	-8.54%	751.42K	Jul 17	View
Apr 03, 2023	Mike Ouimette	GENERAL COUNSEL & CORP. SEC'Y	-7.75K	$26.62	-$206.33K	SELL	-13.24%	50.79K	Mar 30 - Apr 03	View
Apr 03, 2023	Eric Lefebvre	CHIEF MEDICAL OFFICER	-11.24K	$26.52	-$298.23K	SELL	-7.16%	145.79K	Mar 30	View
Apr 03, 2023	Hans Hull	CHIEF BUSINESS OFFICER	-9.04K	$26.52	-$239.64K	SELL	-4.02%	215.95K	Mar 30	View
Apr 03, 2023	Lamont Keith Cummings	CHIEF FINANCIAL OFFICER	-9.96K	$26.52	-$264.15K	SELL	-6.29%	148.47K	Mar 30	View
Apr 03, 2023	Bernard Coulie	PRESIDENT AND CEO	-35.34K	$26.52	-$937.22K	SELL	-4.91%	684.07K	Mar 30	View
Feb 06, 2023	Bernard Coulie	PRESIDENT AND CEO	0.00	$20.07	-$830.83K	SELL-OPTIONS	0.00%	649.43K	Feb 02 - Feb 03	View
Feb 01, 2023	Bernard Coulie	PRESIDENT AND CEO	0.00	$19.18	-$1.38M	SELL-OPTIONS	0.00%	649.43K	Jan 30 - Feb 01	View
Jan 27, 2023	Bernard Coulie	PRESIDENT AND CEO	121.30K	$18.70	-$1.88M	SELL-OPTIONS	42.12%	409.32K	Jan 25 - Jan 27	View
Jan 25, 2023	Bernard Coulie	PRESIDENT AND CEO	-15.00K	$17.60	-$1.89M	SELL	-13.79%	93.81K	Jan 23 - Jan 25	View
Jan 25, 2023	Mike Ouimette	GENERAL COUNSEL & CORP. SEC'Y	0.00	$26.14	-$322.08K	SELL-OPTIONS	0.00%	5.95K	Jan 23	View
Jan 25, 2023	Eric Lefebvre	CHIEF MEDICAL OFFICER	-67.50K	$34.48	-$2.33M	SELL	-46.74%	76.93K	Jan 23	View
Jan 25, 2023	Lamont Keith Cummings	CHIEF FINANCIAL OFFICER	0.00	$19.75	-$915.15K	SELL-OPTIONS	0.00%	84.42K	Jan 23	View
Jan 09, 2023	Bernard Coulie	PRESIDENT AND CEO	0.00	$10.58	-$339.81K	SELL-OPTIONS	0.00%	543.13K	Jan 06 - Jan 09	View
Jan 05, 2023	Bernard Coulie	PRESIDENT AND CEO	0.00	$10.64	-$513.49K	SELL-OPTIONS	0.00%	543.13K	Jan 03 - Jan 04	View
Dec 23, 2022	Mike Ouimette	GENERAL COUNSEL & CORP. SEC'Y	-2.93K	$19.38	-$56.73K	SELL	-32.99%	5.95K	Dec 22	View
Dec 21, 2022	Lamont Keith Cummings	CHIEF FINANCIAL OFFICER	9.73K	$19.10	-$184.20K	GRANT	13.77%	80.42K	Dec 19 - Dec 20	View
Dec 21, 2022	Bernard Coulie	PRESIDENT AND CEO	34.54K	$19.10	-$653.53K	GRANT	6.79%	543.13K	Dec 19 - Dec 20	View
Dec 21, 2022	Eric Lefebvre	CHIEF MEDICAL OFFICER	10.99K	$19.10	-$207.97K	GRANT	8.24%	144.43K	Dec 19 - Dec 20	View
Dec 21, 2022	Mike Ouimette	GENERAL COUNSEL & CORP. SEC'Y	8.88K	$19.10	-$90.14K	GRANT	∞	8.88K	Dec 19 - Dec 20	View
Dec 21, 2022	Hans Hull	CHIEF BUSINESS OFFICER	8.83K	$19.10	-$167.11K	GRANT	6.16%	152.18K	Dec 19 - Dec 20	View
Oct 27, 2022	Eric Lefebvre	CHIEF MEDICAL OFFICER	-5.00K	$25.05	-$125.24K	SELL	-3.61%	133.44K	Oct 25	View
Sep 14, 2022	Bernard Coulie	PRESIDENT AND CEO	0.00	$12.31	-$255.85K	SELL-OPTIONS	0.00%	508.59K	Sep 12	View
Jul 13, 2022	Eric Lefebvre	CHIEF MEDICAL OFFICER	-3.00K	$20.00	-$60.00K	SELL	-2.12%	138.44K	Jul 11	View
Jul 13, 2022	Bernard Coulie	PRESIDENT AND CEO	0.00	$12.29	-$561.51K	SELL-OPTIONS	0.00%	508.59K	Jul 11 - Jul 12	View
Jun 22, 2021	Eric Lefebvre	CHIEF MEDICAL OFFICER	-12.50K	$28.87	-$360.82K	SELL	-8.36%	137.08K	Jun 18	View
Jun 15, 2021	Bernard Coulie	PRESIDENT AND CEO	-4.00K	$33.03	-$132.10K	SELL	-0.79%	504.16K	Jun 14	View
May 17, 2021	Bernard Coulie	PRESIDENT AND CEO	-3.50K	$28.64	-$100.22K	SELL	-0.68%	508.16K	May 14	View
Apr 15, 2021	Bernard Coulie	PRESIDENT AND CEO	2.50K	$16.21	-$93.68K	SELL-OPTIONS	0.55%	456.82K	Apr 13 - Apr 14	View
Mar 19, 2021	Eric Lefebvre	CHIEF MEDICAL OFFICER	-12.50K	$39.41	-$492.68K	SELL	-7.71%	149.58K	Mar 18	View
Mar 17, 2021	Bernard Coulie	PRESIDENT AND CEO	-3.50K	$38.52	-$134.83K	SELL	-0.68%	509.16K	Mar 15	View
Feb 17, 2021	Bernard Coulie	PRESIDENT AND CEO	-3.50K	$32.67	-$114.35K	SELL	-0.68%	512.66K	Feb 16	View
Jan 15, 2021	Bernard Coulie	PRESIDENT AND CEO	-3.50K	$26.38	-$92.33K	SELL	-0.67%	516.16K	Jan 14	View
Dec 21, 2020	Eric Lefebvre	—	-12.50K	$26.54	-$331.75K	SELL	-7.16%	162.08K	Dec 18	View
Dec 16, 2020	Bernard Coulie	—	-3.50K	$27.37	-$95.79K	SELL	-0.67%	519.66K	Dec 14	View
Dec 02, 2020	Lamont Keith Cummings	—	0.00	$16.83	-$493.50K	OPTION EXERCISE	0.00%	23.12K	Dec 01	View

FAQ

Is insider trading legal?

Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.

What are some examples of market manipulation?

Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

Browse insider trades on all stocks.